It causes an itchy rash spread through close skin contact and is very hard to get rid of - and doctors often fail to diagnose ...
TRex Bio banked a Series B extension to advance its atopic dermatitis program, which is competing in a crowded field.
Topical steroid withdrawal occurs when the body becomes addicted to, and physically dependent on, topical corticosteroids, ...
"I always felt like there was just something wrong with me," Michelle Smith told Newsweek, after years of itchy skin.
Nummular eczema is a debilitating skin condition that is distinct from atopic dermatitis but involves similar disease ...
Nearly 9 in 10 adults and parents of children with plaque psoriasis, atopic dermatitis, and seborrheic dermatitis being ...
Sanofi (EPA: SASY) has announced encouraging late-stage clinical trial results for its investigational drug amlitelimab, ...
The ADHAND trial has demonstrated that tralokinumab significantly improved skin clarity, itch, and pain in adults with moderate-to-severe hand atopic dermatitis. All primary and secondary ...
Lawrence Eichenfield, MD, outlines a patient-centered approach to atopic dermatitis, assessing disease history, life impact, and prior therapy use.
Corvus Pharma (CRVS) stock surges as the company plans a Phase 2 trial for its lead asset against eczema following ...
Sitryx advances development of PKM2 modulator SYX-5219 into atopic dermatitis patients following clinical evidence of ...
Sanofi has reported mixed phase 3 data on amlitelimab, further muddying the prospec | Sanofi has reported mixed phase 3 data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results